Arbeitspapier
What do drug monopolies cost consumers in developing countries?
This paper quantifi es the effects of drug monopolies and low per-capita income on pharmaceutical prices in developing economies using the example of the antiretroviral drugs (ARVs) used to treat HIV.
- Sprache
-
Englisch
- Erschienen in
-
Series: Staff Report ; No. 530
- Klassifikation
-
Wirtschaft
Trade Policy; International Trade Organizations
Chemicals; Rubber; Drugs; Biotechnology; Plastics
Intellectual Property and Intellectual Capital
- Thema
-
intellectual property rights
international price discrimination
TRIPS agreement
pharmaceutical industry
markups
- Ereignis
-
Geistige Schöpfung
- (wer)
-
Hellerstein, Rebecca
- Ereignis
-
Veröffentlichung
- (wer)
-
Federal Reserve Bank of New York
- (wo)
-
New York, NY
- (wann)
-
2011
- Handle
- Letzte Aktualisierung
-
10.03.2025, 11:43 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Arbeitspapier
Beteiligte
- Hellerstein, Rebecca
- Federal Reserve Bank of New York
Entstanden
- 2011
Ähnliche Objekte (12)
What does improved fuel economy cost consumers and what does it cost taxpayers? Some illustrations
Psychosocial rehabilitation according to drug consumers' perspective
Psychosocial rehabilitation according to drug consumers' perspective
Active Ingredients: Exploring the Key Factors Affecting the Rising Cost of Developing New Drugs
Nutritional Labeling Today: What Consumers Want - and What They Understand
Consensus, at what Cost?
More cost-sharing, less cost? Evidence on reference price drugs
Low cost housing in developing countries
Guidelines for developing national drug policies
The drugs economy and anti-drug policy in developing countries
What Do Consumers Think About Your Brand? Just Ask!
What he cost her, Vol. 2
What does improved fuel economy cost consumers and what does it cost taxpayers? Some illustrations
Psychosocial rehabilitation according to drug consumers' perspective
Psychosocial rehabilitation according to drug consumers' perspective
Active Ingredients: Exploring the Key Factors Affecting the Rising Cost of Developing New Drugs
Nutritional Labeling Today: What Consumers Want - and What They Understand
Consensus, at what Cost?
More cost-sharing, less cost? Evidence on reference price drugs
Low cost housing in developing countries
Guidelines for developing national drug policies
The drugs economy and anti-drug policy in developing countries
What Do Consumers Think About Your Brand? Just Ask!
What he cost her, Vol. 2
What does improved fuel economy cost consumers and what does it cost taxpayers? Some illustrations
Psychosocial rehabilitation according to drug consumers' perspective
Psychosocial rehabilitation according to drug consumers' perspective
Active Ingredients: Exploring the Key Factors Affecting the Rising Cost of Developing New Drugs
Nutritional Labeling Today: What Consumers Want - and What They Understand
Consensus, at what Cost?
More cost-sharing, less cost? Evidence on reference price drugs
Low cost housing in developing countries
Guidelines for developing national drug policies
The drugs economy and anti-drug policy in developing countries
What Do Consumers Think About Your Brand? Just Ask!